glycine has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indantadol is an oral and nonselective monoamine oxidase inhibitor and NMDA antagonist that is being developed by Vernalis plc, under license from Chiesi Farmaceutici SpA, for the potential treatment of neuropathic pain." | 8.84 | Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain. ( Coluzzi, F; Mattia, C, 2007) |
| "Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine." | 7.74 | Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment. ( Kodama, D; Ono, H; Takasu, K; Tanabe, M; Yamaguchi, S, 2008) |
| "Indantadol is an oral and nonselective monoamine oxidase inhibitor and NMDA antagonist that is being developed by Vernalis plc, under license from Chiesi Farmaceutici SpA, for the potential treatment of neuropathic pain." | 4.84 | Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain. ( Coluzzi, F; Mattia, C, 2007) |
| "Mice with thermal and mechanical hypersensitivity after partial ligation of the sciatic nerve (Seltzer model) or mice with mechanical hypersensitivity after streptozotocin injection received intrathecal injection of glycine, sarcosine, and N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine." | 3.74 | Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment. ( Kodama, D; Ono, H; Takasu, K; Tanabe, M; Yamaguchi, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Yao, W | 1 |
| Gao, Y | 1 |
| Nguyen, HT | 1 |
| Bhattarai, JP | 1 |
| Park, SJ | 1 |
| Lee, JC | 1 |
| Cho, DH | 1 |
| Han, SK | 1 |
| Muñoz-Carlin, Mde L | 1 |
| Rodríguez-Moctezuma, JR | 1 |
| Gómez Latorre, JG | 1 |
| Montes-Castillo, ML | 1 |
| Juárez-Adauta, S | 1 |
| Reismann, P | 2 |
| Rudofsky, G | 1 |
| Witte, S | 1 |
| Humpert, PM | 1 |
| Isermann, B | 1 |
| Chavakis, T | 1 |
| Tafel, J | 1 |
| Nosikov, VV | 1 |
| Hamann, A | 1 |
| Nawroth, P | 1 |
| Bierhaus, A | 1 |
| Wang, XL | 1 |
| Zhang, HM | 1 |
| Chen, SR | 1 |
| Pan, HL | 1 |
| Mattia, C | 1 |
| Coluzzi, F | 1 |
| Tanabe, M | 1 |
| Takasu, K | 1 |
| Yamaguchi, S | 1 |
| Kodama, D | 1 |
| Ono, H | 1 |
| Cangialosi, G | 1 |
| Doria, G | 1 |
| Costa, R | 1 |
| Cirrincione, M | 1 |
| Salerno, V | 1 |
| Allegra, G | 1 |
| Scaffidi, A | 1 |
| Field, MJ | 1 |
| McCleary, S | 1 |
| Boden, P | 1 |
| Suman-Chauhan, N | 1 |
| Hughes, J | 1 |
| Singh, L | 1 |
| Bilska, A | 1 |
| Włodek, L | 1 |
2 reviews available for glycine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain.
Topics: Analgesics; Animals; Anticonvulsants; Clinical Trials as Topic; Diabetic Neuropathies; Glycine; Huma | 2007 |
[Biologic properties of lipoic acid].
Topics: Acquired Immunodeficiency Syndrome; Aging; Animals; Antioxidants; Cataract; Decarboxylation; Diabeti | 2002 |
9 other studies available for glycine and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Effects of Tang Luo Ning on diabetic peripheral neuropathy in rats revealed by LC-MS metabolomics approach.
Topics: Animals; Chromatography, Liquid; Citrates; Diabetes Mellitus; Diabetic Neuropathies; Glycine; Metabo | 2022 |
Enhanced GABA action on the substantia gelatinosa neurons of the medullary dorsal horn in the offspring of streptozotocin-injected mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diabetic Neuropathies; Facial Nerve | 2015 |
[Effects of glycine on auditory evoked potentials among diabetic patients with auditory pathway neuropathy].
Topics: Audiometry; Auditory Pathways; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Evoked Potentials, | 2010 |
[Study of the Toll-like receptor 4 gene polymorphisms in diseases presenting with subclinical and chronic inflammation].
Topics: Alleles; Aspartic Acid; Brain Ischemia; Chronic Disease; Cytokines; Diabetes Complications; Diabetic | 2011 |
Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes.
Topics: Amino Acid Substitution; Aspartic Acid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabet | 2004 |
Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy.
Topics: Animals; Baclofen; Bicuculline; Diabetic Neuropathies; Disease Models, Animal; Excitatory Postsynapt | 2007 |
Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
Topics: Acute Disease; Analgesics; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glycine; | 2008 |
[The motility of the biliary tract studied with 99mTc-Br-IDA in patients with type-2 diabetes mellitus].
Topics: Aged; Aniline Compounds; Biliary Tract; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fasting; F | 1995 |
Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
Topics: Animals; Benzofurans; Carbamates; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophy | 1998 |